Berberine, Zinc, and Quercetin in the Context of Rising Consumer Interest in Natural GLP-1 Support and Non-Prescription ...

Independent Analysis Examines ColonBroom GLP-1 Booster Ingredient Transparency, Non-Prescription Supplement Category Context, ...

Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...

Sedentary lifestyles, poor sleep, stress, and ultra-processed diets are driving hormonal inflammation in young adults. A ...

Experts emphasized that obesity is a chronic, relapsing condition and lifelong therapy—in some form—will be necessary.

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce ...

Winselow Tucker, president and general manager, Eli Lilly and Company (India) Pvt Ltd, addresses concerns regarding ...

A clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, with research and development operations ...

Incregen Therapeutics Advances First-in-Class GIP Ligand Antagonist INC-118 into IND-Enabling Development to Address Long-Term Obesity Management INC-118 directly antagonizes the circulating Glucose ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...